| Literature DB >> 22988471 |
S Saha1, M K Mukhopadhyay, P D Ghosh, D Nath.
Abstract
The aim of the present study was to investigate the protective role of methanolic leaf extract of Ocimum basilicum L. against benzene-induced hematotoxicity in Swiss albino mice. GC analysis and subacute toxicity level of the extract were tested. Mice were randomly divided into three groups among which II and III were exposed to benzene vapour at a dose 300 ppm × 6 hr/day × 5 days/week for 2 weeks and group I was control. Group III of this experiment was treated with the leaf methanolic extract at a dose of 100 mg/kg body weight, a dose in nontoxic range. Hematological parameters (Hb%, RBC and WBC counts), cell cycle regulatory proteins expression and DNA fragmentation analysis of bone marrow cells was performed. There was an upregulation of p53 and p21 and downregulation of levels of CDK2, CDK4, CDK6, and cyclins D1 and E in leaf extract-treated group. DNA was less fragmented in group III compared to group II (P < 0.05). The present study indicates that the secondary metabolites of O. basilicum L. methanolic leaf extract, comprising essential oil monoterpene geraniol and its oxidized form citral as major constituents, have modulatory effect in cell cycle deregulation and hematological abnormalities induced by benzene in mice.Entities:
Year: 2012 PMID: 22988471 PMCID: PMC3440934 DOI: 10.1155/2012/176385
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Treatment schedule.
| Groups | Treatment |
|---|---|
| I | Not received any treatment |
| II | Benzene exposed, received only vehicle, distilled water containing 10% DMSO |
| III | Benzene exposed, received plant extract suspended in distilled water containing 10% DMSO at a dose of 100 mg/kg body weight for 4 weeks |
Percentage composition of the essential oils of Ocimum basilicum L. cultivated in West Bengal.
| Compound | aRetention indices (RI) in min. | bEssential oil (%) |
|---|---|---|
|
| 4.76 | 0.23 |
| Camphor | 4.87 | 0.64 |
| Citral | 5.26 | 23.51 |
| Geraniol | 5.76 | 34.89 |
| Cineole | 5.83 | 0.05 |
|
| 5.92 | 0.19 |
| Citronellal | 5.96 | 0.59 |
| Eugenol | 6.57 | 1.33 |
| Vanillin | 6.72 | 0.27 |
| Linalool | 7.41 | 2.21 |
| Methanol | — | — |
aIdentification of oil components was based on their relative retention indices (retention times) with those of authentic standards.
bQuantitative estimation was done by analysis of FID area percent data.
Figure 1Chromatograms GC analysis of essential oils from Ocimum basilicum L.
Evaluation of nontoxicity of the plant material. Effect of leaf methanolic extract on serum biochemical, hematological parameters, and body weight after subacute administration. Data are represented as mean ± SEM.
| Parameters | Control | Lower dose (50 mg/Kg body weight) | Higher dose (1500 mg/Kg body weight) |
|---|---|---|---|
| (group I) | (group II) | (group III) | |
| SGOT (IU/dL) | 40.75 ± 1.12 | 41.08 ± 1.19 | 40.96 ± 1.15 |
| SGPT (IU/ dL) | 34.22 ± 1.19 | 34.98 ± 1.16 | 35.11 ± 1.13 |
| ALP (IU/dL) | 81.12 ± 1.78 | 80.56 ± 1.76 | 80.01 ± 1.72 |
| Bilirubin (mg/dL) | 0.86 ± 0.13 | 0.85 ± 0.11 | 0.86 ± 0.12 |
| Cholesterol (mg/dL) | 149.25 ± 9.3 | 150.33 ± 8.7 | 150.69 ± 8.9 |
| Total protein (mg/dL) | 6.90 ± 2.09 | 6.89 ± 2.01 | 6.98 ± 2.33 |
| Urea (mg/dL) | 41.64 ± 1.32 | 42.09 ± 1.21 | 42.67 ± 1.31 |
| Uric acid (mg/dL) | 5.48 ± 1.77 | 5.12 ± 1.56 | 5.19 ± 1.67 |
| Creatinine (mg/mL) | 0.93 ± 0.12 | 0.91 ± 0.21 | 0.92 ± 0.18 |
| RBC (× 1012/L) | 6.6 ± 0.12 | 6.6 ± 0.16 | 6.7 ± 0.13 |
| Hb (g/dL) | 13.2 ± 0.22 | 13.1 ± 0.28 | 12.9 ± 0.31 |
| WBC (× 109/L) | 31.3 ± 0.42 | 31.2 ± 0.0.38 | 32.1 ± 0.26 |
| Platelet (× 109/L) | 756 ± 41.2 | 736 ± 46.1 | 750 ± 42.4 |
| Body weight (g) | 23 ± 1.2 | 23 ± 1.5 | 23 ± 1.4 |
Figure 2Immunoblotting of p53, p21, CDK2, cyclin E, CDK4, CDK6, cyclin D1. Panel 1: proteins from control animal; panel 2: proteins from benzene exposed animal; panel 3: proteins from animal treated with plant extract.
Variation of blood parameters among BE (benzene exposed) mice and treated with PE (plant extract) group. Data are expressed as mean ± SEM.
| Group | Hb (g%) | RBC (× 1012/L) | WBC (× 109/L) |
|---|---|---|---|
| Control | 13.29 ± 2.1 | 4.08 ± 0.38 | 8.21 ± 1.2 |
| BE | 9.96 ± 1.3 | 2. 11 ± 0.19 | 3.28 ± 0.45 |
| Treated with PE | 11.96 ± 1.22* | 3.26 ± 0.33* | 4.67 ± 0.31* |
*Significant increase (P < 0.05) in parameters.
Variation of differential blood parameters among BE (benzene-exposed) mice and treated with PE (plant extract) group. Data are expressed as mean ± SEM.
| Group | Differential leukocyte count | Differential of RBC | Platelet count | |||||
|---|---|---|---|---|---|---|---|---|
| Neutrophil (%) | Monocyte (%) | Lymphocyte (%) | Hct (%) | MCV ( | MCH (pg) | MCHC (g/dL) | (× 109/L) | |
| Control | 22.03 ± 1.98 | 1.92 ± 0.06 | 68.34 ± 5.12 | 38.09 ± 2.11 | 52.78 ± 3.46 | 16.22 ± 0.12 | 26.44 ± 0.35 | 750 ± 38.21 |
| BE | 21.68 ± 1.32 | 1.88 ± 0.05 | 48.49 ± 3.51 | 10.23 ± 0.96 | 47.55 ± 2.98 | 14.11 ± 0.14 | 24.33 ± 0.38 | 798 ± 40.08 |
| Treated with PE | 21.92 ± 1.41 | 1.90 ± 0.06 | 62.12 ± 4.98* | 24.35 ± 1.67* | 48.34 ± 2.76 | 14.56 ± 0.13 | 24.49 ± 0.36 | 776 ± 39.97 |
*Significant increase (P < 0.05) in parameters.
Figure 3DNA fragmentation analysis (lane 1, M: marker; lane 2, control DNA; lane 3: DNA from benzene-exposed group; lane 4: DNA from plant extract-treated group).